$94.99 $3.16 per serving
Product analysis
Vital Brain Powder combines several brain-focused ingredients, but its relatively high cost for the carnitine and Alpha-GPC contributions weakens value. The ingredient preparations are not specified well enough for a useful quality comparison.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
All three active ingredients have unspecified preparations. Their names alone do not settle their relative preparation quality.
Ingredient Transparency63
Ingredient amounts are disclosed. Missing preparation details make like-for-like comparisons harder.
Value For Money22
The serving is expensive relative to its acetyl L-carnitine and Alpha-GPC contributions. Value for phosphatidylserine remains uncertain.
Customer Satisfaction70
Customer ratings are strongly favorable. Very few ratings are available, so the satisfaction picture is limited.
Product Focus66
The ingredient mix stays relatively compact despite a broad set of intended uses. That breadth makes the intended practical benefit less focused.
- Format
Powder - Container
- 150 Gram(s)
- Per serving
- $3.16
- Customer rating
- 4.7 · 20 ratings
Goals
Impact
High effect
Acetyl L-Carnitine · 850 mgAcetyl L-Carnitine · 850 mgAlpha-GPC · 600 mg
Impact
High effect
Acetyl L-Carnitine · 850 mgAlpha-GPC · 600 mg
Phospholipids (unspecified) Not classified
No linked studies yet.
Impact
Highest effect
Alpha-GPC · 600 mgAcetyl L-Carnitine · 850 mg
Impact
High effect
Alpha-GPC · 600 mg
Phospholipids (unspecified) Not classified
No linked studies yet.
Impact
High effect
Acetyl L-Carnitine · 850 mg
Impact
Moderate effect
Alpha-GPC · 600 mg
Alpha-GPC Not classified
No linked studies yet.
Impact
Lower effect
Acetyl L-Carnitine · 850 mg
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Acetyl L-Carnitine HCl | 850 mg | |
GlyceroPhosphoCholine | 600 mg | |
Phosphatidylserine | 150 mg |
Acetyl L-Carnitine · 850 mg OverallScore75
A serving provides 850 mg of acetyl L-carnitine HCl, with a high whole-product cost per 500 mg. No purity testing or manufacturing claim is available in the information provided.
How this ingredient is rated
Active Ingredient Quality & Bioavailability88
The carnitine is acetyl L-carnitine HCl. No purity testing or manufacturing claim is available in the information provided.
ALCAR vs. Standard Carnitine Form
The listed carnitine is acetyl L-carnitine.
Advanced Sourcing and Salt Specificity
The HCl form is specified. No purity testing or manufacturing claim is available in the information provided.
Dose, Safety & Label Transparency100
The serving amount is clearly stated as 850 mg.
Clinical Dosage Efficacy
A serving contains 850 mg of acetyl L-carnitine.
Label Transparency and Proprietary Blends
The individual acetyl L-carnitine amount is stated.
Value0
The whole-product cost per 500 mg of acetyl L-carnitine is high.
Price per 500mg Acetyl L-Carnitine
The whole-product cost per 500 mg of acetyl L-carnitine is high.
Alpha-GPC · 600 mg OverallScore44
The serving provides 600 mg of Alpha-GPC, with a high cost for the amount. The Alpha-GPC form and source are not specified. The active amount is stated, but a separate yield is not.
How this ingredient is rated
Active Ingredient Quality & Bioavailability10
The Alpha-GPC form and source are not specified.
Patented/Branded Form and Source
The Alpha-GPC form and source are not specified.
Dose, Safety & Label Transparency80
A serving provides 600 mg of Alpha-GPC. A separate active-yield statement is not available.
Active Alpha-GPC Dosage
The stated active Alpha-GPC amount is 600 mg per serving.
Label Transparency & Yield Disclosure
The active amount is stated, but a separate active-yield statement is not available.
Value40
The cost for the stated Alpha-GPC amount is high.
Price per 300mg Active Alpha-GPC
The cost per 300 mg of Alpha-GPC is high.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
- Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
- Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
- Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
- Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
- Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
- Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
- Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
- Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men.
- Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
- A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
- Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
- [Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Dementia: Meta-Analysis and Systematic Review].
- Vertical Association Between Dietary Total Choline and L-alpha-glycerylphosphorylcholine and the Cognitive Function in Chinese Adults Aged over 55, Result from China Health and Nutrition Survey 1997-2018.
- Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
- The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.
- Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
- A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.
- Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review.
- Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial.